The effectiveness of education of methicillin-resistant Staphylococcus aureus (MRSA) infection prevention and control (IPC) with directive discourse to improve handwashing compliance

2020 ◽  
Vol 30 ◽  
pp. 209-212
Author(s):  
Kusbaryanto
Keyword(s):  
Staphylococcus Aureus ◽  
Prevention And Control ◽  
Infection Prevention ◽  
Methicillin Resistant Staphylococcus Aureus ◽  
Infection Prevention And Control ◽  
Methicillin Resistant ◽  
Mrsa Infection ◽  
And Control

scholarly journals Staphylococcus aureus in poultry, with special emphasis on methicillin-resistant strain infection: A comprehensive review from one health perspective

2021 ◽  
pp. 257-267
Author(s):  
Wafaa A. Abd El-Ghany
Keyword(s):  
Staphylococcus Aureus ◽  
Prevention And Control ◽  
Close Contact ◽  
Control Strategies ◽  
Infected Individual ◽  
Surface Proteins ◽  
Methicillin Resistant ◽  
Mrsa Infection ◽  
Mrsa Strains ◽  
And Control

Staphylococcus aureus is a Gram-positive coccus normally present on the skin and internal organs of animals, birds, and humans. Under certain conditions, S. aureus could produce septicemia and affection of the skin, joints, and heart, as well as sepsis and death. The pathogenicity of S. aureus is associated with the presence of some virulent surface proteins and the production of some virulent toxins and enzymes. This pathogen is considered one of the most important and worldwide foodborne causes as it is incriminated in most cases of food poisoning. The hazardous use of antibiotics in the veterinary field leads to the development of multidrug-resistant S. aureus strains that can be transmitted to humans. The incidence of methicillin-resistant S. aureus (MRSA) strains has increased globally. These resistant strains have been detected in live animals, poultry, and humans. In addition, retail animal products, especially those of avian origin, are considered the main source of MRSA strains that can be easily transmitted to humans. MRSA infection is regarded as nosocomial or occupational. Humans get infected with MRSA strains through improper handling or preparation of contaminated animals or poultry carcasses or improper cooking with contaminated meat. Live birds also can transmit MRSA to close-contact workers in poultry farms. Transmission of MRSA infection in hospitals is from an infected individual to a healthy one. Prevention and control of MRSA are based on the application of hygienic measures in farms as well as proper processing, handling, and cooking of retail poultry products. The cooperation between veterinary and human practitioners is a must to avoid the possibility of zoonotic transmission. Accordingly, this review focused on the sources and transmission of MRSA infection, virulence and resistance factors, incidence and prevalence in poultry and different products, antibiotic resistance, and prevention and control strategies.

scholarly journals Methicillin-resistant Staphylococcus aureus (MRSA): burden of disease and control challenges in Europe

2010 ◽  
Vol 15 (41) ◽  
Author(s):  
R Köck ◽  
K Becker ◽  
B Cookson ◽  
J E van Gemert-Pijnen ◽  
S Harbarth ◽  
...  
Keyword(s):  
Staphylococcus Aureus ◽  
Prevention And Control ◽  
Methicillin Resistant Staphylococcus Aureus ◽  
Health Priorities ◽  
The European Union ◽  
Human Pathogens ◽  
Member States ◽  
Methicillin Resistant ◽  
Eu Member States ◽  
And Control

Methicillin-resistant Staphylococcus aureus (MRSA) is a major cause of healthcare- and community-associated infections worldwide. Within the healthcare setting alone, MRSA infections are estimated to affect more than 150,000 patients annually in the European Union (EU), resulting in attributable extra in-hospital costs of EUR 380 million for EU healthcare systems. Pan-European surveillance data on bloodstream infections show marked variability among EU Member States in the proportion of S. aureus that are methicillin-resistant, ranging from less than 1% to more than 50%. In the past five years, the MRSA bacteraemia rates have decreased significantly in 10 EU countries with higher endemic rates of MRSA infections. In addition to healthcare-associated infections, new MRSA strains have recently emerged as community- and livestock-associated human pathogens in most EU Member States. The prevention and control of MRSA have therefore been identified as public health priorities in the EU. In this review, we describe the current burden of MRSA infections in healthcare and community settings across Europe and outline the main threats caused by recent changes in the epidemiology of MRSA. Thereby, we aim at identifying unmet needs of surveillance, prevention and control of MRSA in Europe.

Comparing the epidemiology of hospital-acquired methicillin-resistant Staphylococcus aureus clone groups in Alberta, Canada

2016 ◽  
Vol 144 (10) ◽  
pp. 2184-2190 ◽  
Author(s):  
S. BRUZZESE ◽  
K. BUSH ◽  
J. LEAL ◽  
J. KIM ◽  
D. M. VICKERS ◽  
...  
Keyword(s):  
Staphylococcus Aureus ◽  
Acute Care ◽  
Infection Prevention ◽  
Care Setting ◽  
Hospital Setting ◽  
Community Setting ◽  
Infection Prevention And Control ◽  
Methicillin Resistant ◽  
Hospital Acquired ◽  
And Control

SUMMARYPatients with methicillin-resistant Staphylococcus aureus (MRSA) clones, which were traditionally seen in the community setting (USA400/CMRSA7 and USA300/CMRSA10), are often identified as hospital-acquired (HA) infections using Infection Prevention and Control (IPC) surveillance definitions. This study examined the demographics and healthcare risk factors of patients with HA-MRSA to help understand if community MRSA clones are from a source internal or external to the hospital setting. Despite USA300/CMRSA10 being the predominant clone in Alberta, hospital clones (USA100/CMRSA2) still dominated in the acute care setting. In the Alberta hospitalized population, patients with USA400/CMRSA7 and USA300/CMRSA10 clones were significantly younger, had fewer comorbidities, and a greater proportion had none or ambulatory care-only healthcare exposure. These findings suggest that there are two distinct populations of HA-MRSA patients, and the patients with USA400/CMRSA7 and USA300/CMRSA10 clones identified in hospital more greatly resemble patients affected by those clones in the community. It is possible that epidemiological assessment overidentifies HA acquisition of MRSA in patients unscreened for MRSA on admission to acute care.

Sign in / Sign up

Export Citation Format

Share Document